US Patent Issued to VGSK Technologies on Oct. 7 for "Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation" (Wisconsin Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,902, issued on Oct. 7, was assigned to VGSK Technologies Inc. (Madison, Wis.).

"Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation" was invented by Kameswari S. Konduri (Madison, Wis.), Ram Pattisapu (Madison, Wis.), Jogi Pattisapu (Madison, Wis.) and John Zwetchkenbaum (Madison, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In some aspects, provided herein are compositions of and methods for utilizing a sterically stabilized liposome carrier encapsulating a selected drug for the delivery of such drug effectual in the treatment of a mammal infected by a virus, such as SARS-COV-2, specifically in inhibiti...